A nitroimidazole derivative, PR-350, enhances the killing of pancreatic cancer cells exposed to high-dose irradiation under hypoxia

Kazuhiro Mizumoto, Li Wu Qian, Li Zhang, Eishi Nagai, Shinobu Kura, Masao Tanaka

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The radiosensitizing effects of PR-350, a nitroimidazole derivative, were examined concerning the cell killing of human pancreatic cancer cell lines exposed to high doses of gamma-ray irradiation in vitro. The percentages of dead cells were analyzed with a multiwell plate reader to measure the fluorescence intensity of propidium iodide before and after a digitonin treatment. The sensitizing effect of PR-350 on cell killing by high-dose irradiation was confirmed by time-course, dose-dependency, and microscopic observations. In five of seven pancreatic cancer cell lines in which the number of dead cells was determined 5 days after 30 Gy irradiation in the presence of PR-350, the number was significantly increased under hypoxic conditions, but not under aerobic conditions. The selective radiosensitive effect of PR-350 on hypoxic cells was also confirmed by flow cytometry. The results indicate that PR-350 can enhance the killing of pancreatic cancer cells by high-dose irradiation under hypoxia, which supports its clinical radiosensitizing effects when administered during intraoperative irradiation to pancreatic cancer.

Original languageEnglish
Pages (from-to)43-51
Number of pages9
JournalJournal of radiation research
Volume43
Issue number1
DOIs
Publication statusPublished - Mar 1 2002

Fingerprint

Nitroimidazoles
hypoxia
Pancreatic Neoplasms
cancer
dosage
irradiation
Radiation-Sensitizing Agents
cultured cells
Digitonin
Cell Line
sensitizing
cytometry
Propidium
Gamma Rays
readers
cells
iodides
Flow Cytometry
Cell Count
Fluorescence

All Science Journal Classification (ASJC) codes

  • Radiation
  • Radiology Nuclear Medicine and imaging
  • Health, Toxicology and Mutagenesis

Cite this

A nitroimidazole derivative, PR-350, enhances the killing of pancreatic cancer cells exposed to high-dose irradiation under hypoxia. / Mizumoto, Kazuhiro; Qian, Li Wu; Zhang, Li; Nagai, Eishi; Kura, Shinobu; Tanaka, Masao.

In: Journal of radiation research, Vol. 43, No. 1, 01.03.2002, p. 43-51.

Research output: Contribution to journalArticle

@article{1dc24132b62b453999917cfae650285e,
title = "A nitroimidazole derivative, PR-350, enhances the killing of pancreatic cancer cells exposed to high-dose irradiation under hypoxia",
abstract = "The radiosensitizing effects of PR-350, a nitroimidazole derivative, were examined concerning the cell killing of human pancreatic cancer cell lines exposed to high doses of gamma-ray irradiation in vitro. The percentages of dead cells were analyzed with a multiwell plate reader to measure the fluorescence intensity of propidium iodide before and after a digitonin treatment. The sensitizing effect of PR-350 on cell killing by high-dose irradiation was confirmed by time-course, dose-dependency, and microscopic observations. In five of seven pancreatic cancer cell lines in which the number of dead cells was determined 5 days after 30 Gy irradiation in the presence of PR-350, the number was significantly increased under hypoxic conditions, but not under aerobic conditions. The selective radiosensitive effect of PR-350 on hypoxic cells was also confirmed by flow cytometry. The results indicate that PR-350 can enhance the killing of pancreatic cancer cells by high-dose irradiation under hypoxia, which supports its clinical radiosensitizing effects when administered during intraoperative irradiation to pancreatic cancer.",
author = "Kazuhiro Mizumoto and Qian, {Li Wu} and Li Zhang and Eishi Nagai and Shinobu Kura and Masao Tanaka",
year = "2002",
month = "3",
day = "1",
doi = "10.1269/jrr.43.43",
language = "English",
volume = "43",
pages = "43--51",
journal = "Journal of Radiation Research",
issn = "0449-3060",
publisher = "Japan Radiation Research Society",
number = "1",

}

TY - JOUR

T1 - A nitroimidazole derivative, PR-350, enhances the killing of pancreatic cancer cells exposed to high-dose irradiation under hypoxia

AU - Mizumoto, Kazuhiro

AU - Qian, Li Wu

AU - Zhang, Li

AU - Nagai, Eishi

AU - Kura, Shinobu

AU - Tanaka, Masao

PY - 2002/3/1

Y1 - 2002/3/1

N2 - The radiosensitizing effects of PR-350, a nitroimidazole derivative, were examined concerning the cell killing of human pancreatic cancer cell lines exposed to high doses of gamma-ray irradiation in vitro. The percentages of dead cells were analyzed with a multiwell plate reader to measure the fluorescence intensity of propidium iodide before and after a digitonin treatment. The sensitizing effect of PR-350 on cell killing by high-dose irradiation was confirmed by time-course, dose-dependency, and microscopic observations. In five of seven pancreatic cancer cell lines in which the number of dead cells was determined 5 days after 30 Gy irradiation in the presence of PR-350, the number was significantly increased under hypoxic conditions, but not under aerobic conditions. The selective radiosensitive effect of PR-350 on hypoxic cells was also confirmed by flow cytometry. The results indicate that PR-350 can enhance the killing of pancreatic cancer cells by high-dose irradiation under hypoxia, which supports its clinical radiosensitizing effects when administered during intraoperative irradiation to pancreatic cancer.

AB - The radiosensitizing effects of PR-350, a nitroimidazole derivative, were examined concerning the cell killing of human pancreatic cancer cell lines exposed to high doses of gamma-ray irradiation in vitro. The percentages of dead cells were analyzed with a multiwell plate reader to measure the fluorescence intensity of propidium iodide before and after a digitonin treatment. The sensitizing effect of PR-350 on cell killing by high-dose irradiation was confirmed by time-course, dose-dependency, and microscopic observations. In five of seven pancreatic cancer cell lines in which the number of dead cells was determined 5 days after 30 Gy irradiation in the presence of PR-350, the number was significantly increased under hypoxic conditions, but not under aerobic conditions. The selective radiosensitive effect of PR-350 on hypoxic cells was also confirmed by flow cytometry. The results indicate that PR-350 can enhance the killing of pancreatic cancer cells by high-dose irradiation under hypoxia, which supports its clinical radiosensitizing effects when administered during intraoperative irradiation to pancreatic cancer.

UR - http://www.scopus.com/inward/record.url?scp=0036515645&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036515645&partnerID=8YFLogxK

U2 - 10.1269/jrr.43.43

DO - 10.1269/jrr.43.43

M3 - Article

C2 - 12056329

AN - SCOPUS:0036515645

VL - 43

SP - 43

EP - 51

JO - Journal of Radiation Research

JF - Journal of Radiation Research

SN - 0449-3060

IS - 1

ER -